EKF Diagnostics (LON:EKF) Stock Passes Above 200-Day Moving Average - Should You Sell?

Key Points

• EKF Diagnostics Holdings plc's stock price has surpassed its 200-day moving average of GBX 24.83, trading as high as GBX 30.45.
• The company has a market capitalization of £130.24 million with a P/E ratio of 2,101.45 and a beta of 0.57.
• EKF Diagnostics specializes in Point-of-Care analysers and life sciences services, operating globally with five manufacturing sites in the US and Germany.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 24.83 ($0.34) and traded as high as GBX 30.45 ($0.42). EKF Diagnostics shares last traded at GBX 29.60 ($0.40), with a volume of 97,053 shares changing hands.

EKF Diagnostics Stock Performance

The firm has a market cap of £134.28 million, a PE ratio of 2,166.67 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The stock has a 50-day moving average price of GBX 28.51 and a 200 day moving average price of GBX 25.04.

EKF Diagnostics (LON:EKF - Get Free Report) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.